• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intern Med . Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population

tetano

Editor, Senior Moderator
Intern Med


. 2020;59(19):2353-2358.
doi: 10.2169/internalmedicine.5777-20. Epub 2020 Oct 1.
Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population


Koichiro Abe[SUP] 1 [/SUP], Takatsugu Yamamoto[SUP] 1 [/SUP], Kotaro Matsumoto[SUP] 2 [/SUP], Kentaro Kikuchi[SUP] 3 [/SUP], Ryo Miura[SUP] 1 [/SUP], Naoko Tachizawa[SUP] 1 [/SUP], Yoshinari Asaoka[SUP] 1 [/SUP], Tomoko Takezawa[SUP] 4 [/SUP], Naohisa Matsunaga[SUP] 4 [/SUP], Shuntaro Obi[SUP] 5 [/SUP], Atsushi Tanaka[SUP] 1 [/SUP]



Affiliations

Abstract

Objective Liver injury is a notable complication of coronavirus disease 2019 (COVID-19). This study aimed to clarify the clinical features and liver injury in Japanese patients with COVID-19. Methods We conducted a multicenter retrospective cohort study. All consecutive patients with COVID-19 who visited or were admitted to our hospital before May 12, 2020, were enrolled. Their demographics, symptoms, laboratory findings, comorbidities, concomitant drugs, treatment, and clinical course were reviewed. We defined liver injury as alanine aminotransferase (ALT) or gamma-glutamyl transferase (GGT) levels over the upper limit of normal. Results Twenty-two patients with COVID-19 (median age, 47 years old; men/women, 13/9) were enrolled. Two patients had underlying liver diseases, and two were diagnosed as having COVID-19 without any symptoms. Elevated ALT and GGT levels were found in 12 and 12 patients, respectively, and liver injury was observed in 15 patients (68.2%). Compared with the patients without liver injury, those with liver injury had a significantly higher fever during the clinical course (median, 37.5?C vs. 38.8?C, p=0.006). A significant correlation was found between the highest serum liver values and the highest body temperature in each patient. Among the 22 patients, 4 required artificial respiratory support, and 2 died thereafter. Liver injury was not associated with the severity or mortality of COVID-19. Conclusion Elevated levels of liver enzymes in the Japanese patients with COVID-19 were associated with the highest body temperature during the clinical course but not with the severity or mortality of COVID-19.

Keywords: COVID-19; SARS-CoV-2; coronavirus; fever; hepatitis; liver injury.
 
Back
Top Bottom